These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 5822623)
41. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. Gangjee A; Adair O; Queener SF J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486 [TBL] [Abstract][Full Text] [Related]
42. [The synthesis of the dihydrofolate reductase inhibitors 2,4-diamino-5-substituted-benzylpyrimidines and their inhibition on L. casei DHFR and chicken liver DHFR]. Fang ZX; Li RL; Jiang YM; Gao JN Yao Xue Xue Bao; 1988 Feb; 23(2):108-14. PubMed ID: 3188916 [No Abstract] [Full Text] [Related]
43. Active-site directed irreversible inhibitors of dihydrofolate reductase. Baker BR Ann N Y Acad Sci; 1971 Nov; 186():214-26. PubMed ID: 4943574 [No Abstract] [Full Text] [Related]
44. 2,4-Diaminothieno[2,3-d]pyrimidine lipophilic antifolates as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase. Rosowsky A; Papoulis AT; Queener SF J Med Chem; 1997 Oct; 40(22):3694-9. PubMed ID: 9357537 [TBL] [Abstract][Full Text] [Related]
45. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity. Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863 [TBL] [Abstract][Full Text] [Related]